FR2281757A1 - Nouvelles compositions pharmaceutiques utiles au traitement de l'hypertension chez les animaux - Google Patents

Nouvelles compositions pharmaceutiques utiles au traitement de l'hypertension chez les animaux

Info

Publication number
FR2281757A1
FR2281757A1 FR7525408A FR7525408A FR2281757A1 FR 2281757 A1 FR2281757 A1 FR 2281757A1 FR 7525408 A FR7525408 A FR 7525408A FR 7525408 A FR7525408 A FR 7525408A FR 2281757 A1 FR2281757 A1 FR 2281757A1
Authority
FR
France
Prior art keywords
hypertension
animals
treatment
pharmaceutical compositions
compositions useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7525408A
Other languages
English (en)
Other versions
FR2281757B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2281757A1 publication Critical patent/FR2281757A1/fr
Application granted granted Critical
Publication of FR2281757B1 publication Critical patent/FR2281757B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7525408A 1974-08-16 1975-08-14 Nouvelles compositions pharmaceutiques utiles au traitement de l'hypertension chez les animaux Granted FR2281757A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49796174A 1974-08-16 1974-08-16
US55437375A 1975-03-03 1975-03-03

Publications (2)

Publication Number Publication Date
FR2281757A1 true FR2281757A1 (fr) 1976-03-12
FR2281757B1 FR2281757B1 (fr) 1980-04-11

Family

ID=27052662

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7525408A Granted FR2281757A1 (fr) 1974-08-16 1975-08-14 Nouvelles compositions pharmaceutiques utiles au traitement de l'hypertension chez les animaux

Country Status (10)

Country Link
AU (1) AU505455B2 (fr)
CA (1) CA1044141A (fr)
CY (1) CY978A (fr)
DE (1) DE2536349A1 (fr)
FR (1) FR2281757A1 (fr)
GB (1) GB1495034A (fr)
HK (1) HK73178A (fr)
KE (1) KE2903A (fr)
MY (1) MY7900033A (fr)
NL (1) NL7508856A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014642A2 (fr) * 1979-02-02 1980-08-20 Merck & Co. Inc. Compositions ophtalmiques comprenant des combinaisons d'inhibiteurs d'anhydrase carbonique et de S-(-)-1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yl)-oxy-2-propanol pour application topique dans le traitement d'hypertension intraoculaire
EP0036351A2 (fr) * 1980-03-04 1981-09-23 Merck & Co. Inc. Compositions ophtalmiques, contenant des inhibiteurs de l'anhydrase carbonique pour l'application locale dans le traitement de l'hypertension intraoculaire

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014642A2 (fr) * 1979-02-02 1980-08-20 Merck & Co. Inc. Compositions ophtalmiques comprenant des combinaisons d'inhibiteurs d'anhydrase carbonique et de S-(-)-1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yl)-oxy-2-propanol pour application topique dans le traitement d'hypertension intraoculaire
EP0014642A3 (en) * 1979-02-02 1981-01-07 Merck & Co. Inc. Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitors and s-(-)-1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yl)-oxy-2-propanol for topical application in the treatment of elevated intraocular pressure
EP0036351A2 (fr) * 1980-03-04 1981-09-23 Merck & Co. Inc. Compositions ophtalmiques, contenant des inhibiteurs de l'anhydrase carbonique pour l'application locale dans le traitement de l'hypertension intraoculaire
EP0036351B1 (fr) * 1980-03-04 1985-01-02 Merck & Co. Inc. Compositions ophtalmiques, contenant des inhibiteurs de l'anhydrase carbonique pour l'application locale dans le traitement de l'hypertension intraoculaire

Also Published As

Publication number Publication date
MY7900033A (en) 1979-12-31
KE2903A (en) 1978-12-01
CY978A (en) 1979-03-23
FR2281757B1 (fr) 1980-04-11
HK73178A (en) 1978-12-22
AU505455B2 (en) 1979-11-22
AU8371375A (en) 1977-02-10
GB1495034A (en) 1977-12-14
DE2536349A1 (de) 1976-02-26
CA1044141A (fr) 1978-12-12
NL7508856A (nl) 1976-02-18

Similar Documents

Publication Publication Date Title
BE823345A (fr) Compositions pharmaceutiques pour empecher l'absorption de cholesterol
BE854414A (fr) Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate
FR2316954A1 (fr) Preparation dentaire pour le traitement de la parodontose
BE827361A (fr) Nouvelle composition destinee au traitement de la mammite chez les animaux producteurs de lait
IT1050326B (it) Composizione per la cura e la pulizia dei pavimenti
BE828555A (fr) Composition pour le traitement d'infections virales
BE837662A (fr) Composition gelifiee contenant de la tretinoine pour le traitement de l'acne
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
FR2277591A1 (fr) Composition pharmaceutique pour la prevention et le traitement de l'alcoolisme
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
FR2281757A1 (fr) Nouvelles compositions pharmaceutiques utiles au traitement de l'hypertension chez les animaux
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE773933A (fr) Nouvelles compositions vitreuses de zinc et d'acides alpha-hydroxy-diphosphoniques
FR2313924A1 (fr) Application de derives de l'acide dithiocarbamique au traitement de la mycoplasmose
BE820222A (fr) Composition therapeutique pour le traitement du diabete par voie orale
BE817547A (fr) Perfectionnements au traitement de la chicoree
FR2332233A1 (fr) Perfectionnement au traitement d'effluents aqueux contenant des composes du soufre
FR2320738A1 (fr) Compositions pharmaceutiques pour traiter l'hypertension
BE829024A (fr) Compositions pharmaceutiques pour le traitement de l'hydropisie
FR2283670A1 (fr) Derives d'acides 19,20-bis-nor-prostanoique, leur preparation et compositions pharmaceutiques les contenant
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
FR2310770A1 (fr) Medicament pour le traitement de l'alopecia areata
FR2310768A1 (fr) Medicament pour le traitement de l'alopecia senilis
BE881763A (fr) Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension

Legal Events

Date Code Title Description
TP Transmission of property